Johnson & Johnson vs AbbVie Inc.
Johnson & Johnson is worth $650.673B, 1.4× the $464.575B market cap of AbbVie Inc.. Updated daily.
| Metric | AbbVie Inc.ABBV  | |
|---|---|---|
| Market cap | $650.673B | $464.575B |
| Global rank | #1 | #2 |
| Share price | $270.00 | $262.90 |
| Change | +3.93% | +5.12% |
| Revenue | $94.193B | $61.160B |
| Net income | $26.804B | $4.226B |
| Country | United States | United States |
| Sector | Healthcare | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Johnson & Johnson bigger than AbbVie Inc.?
- Johnson & Johnson has a market cap of $650.673B against $464.575B for AbbVie Inc., making it 1.4 times as valuable.
- Which company earns more, JNJ or ABBV?
- Johnson & Johnson reported net income of $26.804B and AbbVie Inc. reported $4.226B in their most recent annual periods.